SCHEMBL6715108

SCHEMBL6715108

CCCCC(Cc1ccc(OCc2ccccc2)cc1)(C(=O)OCC)C(=O)OCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
LMNA P02545 1/20 0.51
ALOX5 P09917 3/20 0.49
ALDH1A1 P00352 2/20 0.49
NR1H4 Q96RI1 1/20 0.49
MAOB P27338 1/20 0.46
FFAR1 O14842 1/20 0.45
FFAR4 Q5NUL3 1/20 0.45
NR4A1 P22736 1/20 0.45
NR4A2 P43354 1/20 0.45
NR4A3 Q92570 1/20 0.45
PPARG P37231 1/20 0.45
PPARD Q03181 1/20 0.45
PPARA Q07869 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
TSPO P30536 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716118 0.93 L3MBTL1 (0.53) L3MBTL1LMNAALOX5ALDH1A1NR1H4
SCHEMBL6714987 0.92 LTA4H (0.51) L3MBTL1LMNAALOX5ALDH1A1NR1H4
SCHEMBL27542889 0.88 LMNA (0.51) L3MBTL1LMNAALOX5ALDH1A1NR1H4
SCHEMBL6713635 0.87 L3MBTL1 (0.50) L3MBTL1LMNAALOX5ALDH1A1NR1H4
SCHEMBL20507235 0.84 PTPRB (0.45) L3MBTL1LMNAALDH1A1PPARGPPARA
SCHEMBL8551082 0.83 ALDH1A1 (0.51) L3MBTL1LMNAALDH1A1PPARGPPARA
SCHEMBL7614913 0.83 S1PR1 (0.55) LMNAALDH1A1FFAR1
SCHEMBL28123741 0.82 ALDH1A1 (0.50) L3MBTL1ALDH1A1PPARGPPARARECQL
SCHEMBL28123756 0.82 TSHR (0.50) L3MBTL1LMNAALDH1A1RECQLMMP8
SCHEMBL15669148 0.81 L3MBTL1 (0.56) L3MBTL1LMNAALOX5ALDH1A1NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
EP-0916651-B1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES SANKYO CO (JP) 2003-10-15 EP disclosed
CN-1104413-C Phenylalkylcarboxylic acid derivatives SANKYO CO (JP) 2003-04-02 CN disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
CN-1280561-A Amidocarboxylic acid derivatives SANKYO CO (JP) 2001-01-17 CN disclosed
US-6103907-A ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT SANKYO COMPANY, LIMITED (JP) 2000-08-15 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed
CN-1219927-A Phenylalkylcarboxylic acid derivatives SANKYO CO (JP) 1999-06-16 CN disclosed
EP-0916651-A1 PHENYLALKYLCARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 1999-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 L3MBTL1 1431/4885LMNA 4239/4885ALOX5 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.